Treatment with standard chemotherapy and dendritic cells pulsed with WT1 peptides for pancreatic cancer
Not Applicable
- Conditions
- unresectable pancreatic cancer
- Registration Number
- JPRN-UMIN000032386
- Lead Sponsor
- The Jikei University School of Medicine, Kashiwa Hospital, Division of Gastroenterology & Hepatology, Department of Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1) pregnancy 2) serious infections 3) severe underlying disease 4) severe allergic disease 5) a judgment of unsuitability by the principal investigator etc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety and toxicity
- Secondary Outcome Measures
Name Time Method the assessment of the immunologic response, tumor response, overall survival (OS), and progression-free survival (PFS) from the first treatment